EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY Trademark

Trademark Overview

On Thursday, March 23, 2006, a trademark application was filed for EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY with the United States Patent and Trademark Office. The USPTO has given the EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY trademark a serial number of 78844268. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 15, 2011. This trademark is owned by Bristol-Myers Squibb Company. The EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and clinical studies
early superior hbv dna reduction with entecavir vs. adefovir (adv) in chronically infected hbeag (+) nucleioside naive adults in a 12-week viral kinetics study

General Information

Serial Number78844268
Word MarkEARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY
Filing DateThursday, March 23, 2006
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 15, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2007

Trademark Statements

Disclaimer with Predetermined Text"SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials and clinical studies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 29, 2006
Primary Code042
First Use Anywhere DateThursday, April 6, 2006
First Use In Commerce DateThursday, April 6, 2006

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, November 15, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 18, 2011NON-FINAL ACTION MAILED
Friday, April 15, 2011SU - NON-FINAL ACTION - WRITTEN
Tuesday, February 22, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 16, 2011USE AMENDMENT FILED
Wednesday, February 16, 2011TEAS STATEMENT OF USE RECEIVED
Friday, August 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, August 5, 2010EXTENSION 5 GRANTED
Monday, July 26, 2010EXTENSION 5 FILED
Monday, July 26, 2010TEAS EXTENSION RECEIVED
Monday, February 1, 2010EXTENSION 4 GRANTED
Friday, January 22, 2010EXTENSION 4 FILED
Friday, January 22, 2010TEAS EXTENSION RECEIVED
Thursday, December 17, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 25, 2009EXTENSION 3 GRANTED
Thursday, July 23, 2009EXTENSION 3 FILED
Monday, August 24, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 23, 2009TEAS EXTENSION RECEIVED
Wednesday, January 28, 2009EXTENSION 2 GRANTED
Wednesday, January 28, 2009EXTENSION 2 FILED
Wednesday, January 28, 2009TEAS EXTENSION RECEIVED
Friday, July 25, 2008EXTENSION 1 GRANTED
Friday, July 25, 2008EXTENSION 1 FILED
Friday, July 25, 2008TEAS EXTENSION RECEIVED
Tuesday, February 26, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2007NOTICE OF PUBLICATION
Tuesday, October 30, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 29, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 11, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 11, 2007ASSIGNED TO LIE
Tuesday, August 28, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 13, 2007NON-FINAL ACTION MAILED
Tuesday, March 13, 2007NON-FINAL ACTION WRITTEN
Tuesday, March 6, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 5, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 5, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 6, 2006NON-FINAL ACTION MAILED
Wednesday, September 6, 2006NON-FINAL ACTION WRITTEN
Thursday, August 24, 2006ASSIGNED TO EXAMINER
Thursday, April 20, 2006NOTICE OF PSEUDO MARK MAILED
Wednesday, March 29, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

adults naive week viral study kinetics nucleioside hbeag reduction superior clinical trials studies conducting namely scientific research medical